Glaukos Total Long Term Liabilities 2014-2025 | GKOS
Glaukos total long term liabilities from 2014 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Glaukos total long term liabilities for the quarter ending March 31, 2025 were $0.134B, a 67.42% decline year-over-year.
- Glaukos total long term liabilities for 2024 were $0.133B, a 67.2% decline from 2023.
- Glaukos total long term liabilities for 2023 were $0.405B, a 1.15% increase from 2022.
- Glaukos total long term liabilities for 2022 were $0.4B, a 0.21% increase from 2021.
| Glaukos Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $133 |
| 2023 | $405 |
| 2022 | $400 |
| 2021 | $399 |
| 2020 | $288 |
| 2019 | $87 |
| 2018 | $3 |
| 2017 | $1 |
| 2016 | $0 |
| 2015 | $1 |
| 2014 | $9 |
| 2013 | $18 |
| Glaukos Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $134 |
| 2024-12-31 | $133 |
| 2024-09-30 | $186 |
| 2024-06-30 | $184 |
| 2024-03-31 | $410 |
| 2023-12-31 | $405 |
| 2023-09-30 | $404 |
| 2023-06-30 | $404 |
| 2023-03-31 | $402 |
| 2022-12-31 | $400 |
| 2022-09-30 | $399 |
| 2022-06-30 | $399 |
| 2022-03-31 | $399 |
| 2021-12-31 | $399 |
| 2021-09-30 | $400 |
| 2021-06-30 | $110 |
| 2021-03-31 | $97 |
| 2020-12-31 | $288 |
| 2020-09-30 | $286 |
| 2020-06-30 | $278 |
| 2020-03-31 | $87 |
| 2019-12-31 | $87 |
| 2019-09-30 | $84 |
| 2019-06-30 | $83 |
| 2019-03-31 | $15 |
| 2018-12-31 | $3 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $1 |
| 2015-09-30 | $3 |
| 2015-06-30 | $12 |
| 2015-03-31 | $14 |
| 2014-12-31 | $9 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.553B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.503B | 85.19 |
| Thermo Fisher Scientific (TMO) | United States | $151.179B | 18.29 |
| Edwards Lifesciences (EW) | United States | $43.872B | 28.76 |
| Alcon (ALC) | Switzerland | $42.488B | 28.71 |
| IDEXX Laboratories (IDXX) | United States | $40.599B | 46.66 |
| DexCom (DXCM) | United States | $33.262B | 51.41 |
| STERIS (STE) | Ireland | $23.954B | 26.41 |
| IQVIA Holdings (IQV) | United States | $23.881B | 13.38 |
| Mettler-Toledo (MTD) | United States | $23.609B | 28.08 |
| Waters (WAT) | United States | $20.737B | 29.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.307B | 0.00 |
| Hologic (HOLX) | United States | $12.141B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $10.330B | 81.08 |
| Masimo (MASI) | United States | $8.128B | 29.98 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Teleflex (TFX) | United States | $5.344B | 8.82 |
| TransMedics (TMDX) | United States | $4.172B | 90.69 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.146B | 30.11 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.990B | 17.89 |
| Alphatec Holdings (ATEC) | United States | $1.824B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.375B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.84 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.73 |
| RxSight (RXST) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.603B | 13.19 |
| NeuroPace (NPCE) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.98 |
| Delcath Systems (DCTH) | United States | $0.562B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.33 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.283B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| 908 Devices (MASS) | United States | $0.170B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.80 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 16.45 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.75 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |